Загрузка...
Aromatase Inhibitor, Tamoxifen and Endometrial Cancer in Breast Cancer Survivors
BACKGROUND: Both endometrial cancer and postmenopausal breast cancer risk are increased by obesity and higher endogenous estrogen levels. While aromatase inhibitors reduce breast cancer incidence, their influence on endometrial cancer is uncertain. METHODS: We addressed this issue in a cohort of 17,...
Сохранить в:
| Опубликовано в: : | Cancer |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565775/ https://ncbi.nlm.nih.gov/pubmed/25757699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29332 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|